These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3755657)

  • 1. The circadian variation of thyrotrophin in patients with primary thyroidal disease.
    Evans PJ; Weeks I; Jones MK; Woodhead JS; Scanlon MF
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):343-8. PubMed ID: 3755657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtle changes in serum thyrotrophin (TSH) and sex-hormone-binding globulin (SHBG) levels during long-term follow-up after radioactive iodine in multinodular non-toxic goitre.
    Jarløv AE; Faber J; Hegedüs L; Hansen JM
    Clin Endocrinol (Oxf); 1992 Oct; 37(4):335-7. PubMed ID: 1483288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays.
    Pedersen IB; Knudsen N; Perrild H; Ovesen L; Laurberg P
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):381-90. PubMed ID: 11589682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
    Bayer MF; Kriss JP; McDougall IR
    J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lack of nocturnal serum thyrotropin surge in patients with nontoxic nodular goiter may predict the subsequent occurrence of hyperthyroidism.
    Bartalena L; Martino E; Velluzzi F; Piga M; Petrini L; Loviselli A; Grasso L; Pinchera A
    J Clin Endocrinol Metab; 1991 Sep; 73(3):604-8. PubMed ID: 1874936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and quantitative measurement by immunoprecipitation assay of anti-thyrotrophin receptor antibodies in sera of patients with Graves' disease.
    de Bruin TW; van der Heide D; Querido A; Krol MC
    Clin Endocrinol (Oxf); 1984 Feb; 20(2):143-51. PubMed ID: 6325045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotrophin displacement activity of serum immunoglobulins in health and disease.
    Croxson MS; Lim TM; Graham FM; Ibbertson HK
    Aust N Z J Med; 1980 Apr; 10(2):151-6. PubMed ID: 6930204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The occurrence of hypothyroidism following radioactive iodine treatment of toxic nodular goiter is related to the TSH level.
    Adamali HI; Gibney J; O'Shea D; Casey M; McKenna TJ
    Ir J Med Sci; 2007 Sep; 176(3):199-203. PubMed ID: 17632747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical value of a sensitive TSH-RIA].
    Seidel C; Ziegelitz D; Weber A; Dittmer T; Gerl H; Knappe G; Correns HJ
    Endokrinologie; 1982 Oct; 80(2):181-93. PubMed ID: 6819129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of conventional and echo colour Doppler sonography in the differential diagnosis of toxic multinodular goitres.
    Boi F; Loy M; Piga M; Serra A; Atzeni F; Mariotti S
    Eur J Endocrinol; 2000 Sep; 143(3):339-46. PubMed ID: 11022175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
    Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidental differentiated thyroid carcinoma is less prevalent in Graves' disease than in multinodular goiter].
    Pascual Corrales E; Príncipe RM; Laguna Muro S; Martínez Regueira F; Alcalde Navarrete JM; Guillén Grima F; Galofré JC
    Endocrinol Nutr; 2012 Mar; 59(3):169-73. PubMed ID: 22325789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term follow-up study of patients with non-toxic diffuse goitre in Japan.
    Hara T; Tamai H; Mukuta T; Fukata S; Kuma K; Nakagawa T
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):541-6. PubMed ID: 8252742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical hyperthyroidism--a graded condition.
    Gemsenjäger E; Girard J
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):521-6. PubMed ID: 6405572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelationship between thyroid nodularity and TSH level.
    Sachmechi I; Vahedi M; Nalamasu S; Vuppalanchi R
    Mt Sinai J Med; 2005 Jan; 72(1):33-5. PubMed ID: 15682260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the clinically significant TSH response to TRH in patients with nodular goitre.
    Kirkegaard C; Bregengård C
    Horm Metab Res; 1988 Jun; 20(6):357-9. PubMed ID: 3138170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of subclinical hyperthyroidism and relationship between thyroid hormonal status and thyroid ultrasonographic parameters in patients with non-toxic nodular goitre.
    Rieu M; Bekka S; Sambor B; Berrod JL; Fombeur JP
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):67-71. PubMed ID: 8348708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.